Johnson & Johnson said it has temporarily halted clinical trials of its COVID-19 vaccine candidate to allow investigation of an unexplained illness in one participant. The company said the patient's condition is being evaluated by its clinical and safety experts and an independent data and safety monitoring board.
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.